Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

Clinical trial results indicate that brentuximab vedotin brings considerable promise for the treatment of patients with relapsed or refractory Hodgkin’s lymphoma. A retrospective multicenter study was conducted on 65 heavily pretreated patients who underwent therapy through a Named Patient Program i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zinzani, Pier Luigi, Viviani, Simonetta, Anastasia, Antonella, Vitolo, Umberto, Luminari, Stefano, Zaja, Francesco, Corradini, Paolo, Spina, Michele, Brusamolino, Ercole, Gianni, Alessandro M., Santoro, Armando, Botto, Barbara, Derenzini, Enrico, Pellegrini, Cinzia, Argnani, Lisa
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3729903/
https://ncbi.nlm.nih.gov/pubmed/23645687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.083048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados